RNA Therapeutics Form Cell to Sales: Clearing the Path to Market
Time:February 16-17, 2015
Venue:Marriott Hotel,Regents Park 128 King Henry's Road London, NW3 3ST United Kingdom
Organizer:SMi Group
RNA Therapeutics 2015 returns to London on 16th and 17th February, gathering a room full of scientific pioneers and industry experts to identify the latest advancements, best practice and strategies to maximise return on investment.
The cutting edge event will ask questions such as:
What are the current opportunities, obstacles and solutions for developing effective RNAi based drugs? What makes CRISPR-Cas special and how can be used as a role model for personalised medicine? Why use a patent to protect a biotech innovation? How do we unlock the potential with locked nucleic acid? How does the next generation of ASOs demonstrate robust target knock down in multiple preclinical cancer models?
Hear case study driven presentations from an array of market leaders such as Roche, CRISPR Therapeutics, Leiden University Medical Centre, MiNa Therapeutics and AstraZeneca, discussing the latest advancements and programmes, CRIPSPR gene editing technologies, hepatic targeting, viral delivery, the patent application process, RNA splicing, plus much more!
KEY SPEAKERS
• Claude Paul Malvy, Professor, Universite Paris Sud - CONFERENCE CHAIR
• Joerg Kaufmann, Chief Scientific Officer, Silence Therapeutics - CONFERENCE CHAIR
• Bo Rode Hansen, VP, Drug Discovery & Alliance, Roche
• Rodger Novak, CEO, CRISPR Therapeutics
• Annemieke Aartsma-Rus, Associate Professor, Leiden University Medical Center
• Nagy Habib, Chairman and Co Founder, MiNa Therapeutics
• David Blakey, Chief Scientist, AstraZeneca
REASONS TO ATTEND
• Take away best practice learning on efficient and targeted efforts to maximise return on investment
• Hear key case studies from leading companies and gain the edge in confronting the challenges of oligonucleotide R&D
• Discover the latest clinical data in RNAi, ASO and miRNA medicine including the latest RNA activation approaches
• Review new conjugate/aptamer/lipid/polymer/nanoparticle delivery systems to enhance the efficacy and bioavailability of compounds
• Update on the state of CRISPR technology for therapy
• Enhance knowledge on intellectual property issues (IP)
Venue
Marriott Hotel, Regents Park
128 King Henry's Road
London, NW3 3ST
United Kingdom
This 4 star north London hotel in zone 2 is the perfect destination for the astute business traveler as well as the leisure guest that knows how convenient north London hotels are, as a base from which to explore the city .Bond Street is just 3 stops from Swiss Cottage underground station on the Jubilee Line, so you can be shopping, exploring the sights and taking in one of London’s world-renowned West End shows in less than 15 minutes when you stay at this hotel near central London. At the same time, the hive of activity that is Camden Town, the chic shops, cafes and restaurants of Primrose Hill and ZSL’s London Zoo in Regents Park are all just a short walk from this hotel in north London.
Pharma Sources Insight July 2025
